Sign in

CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company

CERENOME, INC.

Sign in to watch
Ticker
CNSY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330827593
Phone
737.255.7194
Business address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Executive or director change
  3. 4 Open-market buy Director bought 7,100 shares at an average $2.55 ($18,098)
  4. 4 Open-market buy Director bought 3,500 shares at $2.57 ($8,990)
  5. 4 Open-market buy Director bought 2,000 shares at an average $2.58 ($5,160)
  6. 4 Open-market buy Director bought 5,000 shares at an average $2.31 ($11,550)
  7. 4 Open-market buy Director bought 2,000 shares at $2.24 ($4,480)
  8. 4 Open-market buy Director bought 7,000 shares at an average $2.14 ($14,976)
  9. 4 Open-market buy Director bought 5,000 shares at $2.14 ($10,700)
  10. 8-K Event Shareholder vote results
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 8-K Event Material agreement · Acquisition or sale completed
  14. ARS Other Annual Report to Security Holders
  15. DEF 14A Proxy Proxy Statement
  16. PRE 14A Proxy Proxy Statement (Preliminary)
  17. 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. 10-K/A Report 10-K/A

Page 45 of 74 · 1,465 filings